Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers.

MLA

Thønnings, Sara, et al. “Cefuroxime Pharmacokinetics and Pharmacodynamics for Intravenous Dosage Regimens with 750 Mg or 1500 Mg Doses in Healthy Young Volunteers.” Journal of Medical Microbiology, vol. 69, no. 3, Mar. 2020, pp. 387–95. EBSCOhost, https://doi.org/10.1099/jmm.0.001138.

APA

Thønnings, S., Jensen, K. S., Nielsen, N. B., Skjønnemand, M., Hansen, D. S., Lange, K. H. W., & Frimodt-Møller, N. (2020). Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers. Journal of Medical Microbiology, 69(3), 387–395. https://doi.org/10.1099/jmm.0.001138

Chicago

Thønnings, Sara, Klaus S Jensen, Ninna B Nielsen, Martin Skjønnemand, Dennis S Hansen, Kai H W Lange, and Niels Frimodt-Møller. 2020. “Cefuroxime Pharmacokinetics and Pharmacodynamics for Intravenous Dosage Regimens with 750 Mg or 1500 Mg Doses in Healthy Young Volunteers.” Journal of Medical Microbiology 69 (3): 387–95. doi:10.1099/jmm.0.001138.